NFMRI Commercialisation Seminar -The-commercialisation journey learnings from Cincera Therapeutics

National Foundation for Medical Research and Innovation (NFMRI), Monash University and Brandon Capital Partners invite you to a Commercialisation Seminar.

Come along and hear about the journey of Cincera Therapeutics Pty Ltd, a 2016 spinout from Monash Institute of Pharmaceutical Science.

Issues highlighted during this adventure.

- How to navigate the commercialisation journey
- How to make your research ”attractive” to investors
- How it all works

Venue: Science Lecture Theatre 10, 16 Rainforest, Clayton campus
Date: Wednesday 13th May from 12 noon – 2 pm (light lunch provided)

Bookings are essential. Further information and to register please click here.

With thanks to our fabulous speakers:

• A/Prof Bernie Flynn - Australian Translational Medicinal Chemistry Facility (ATMCF), MIPS Medicinal Chemistry. A researcher’s perspective and experience navigating through the system.
• Dr Noel Chambers (National Foundation for Medical Research and Innovation (NFMRI). Translation and the role of a Philanthropic funding in the valley of death.
• Dr Kathy Nielsen - Director, Life Sciences, Monash Innovation. University support, intellectual property management, commercialisation strategy and assistance.
• Dr Michael Bettes - Investment Manager, Brandon Capital Partners representing the Medical Research Commercialisation Fund (MRCF). Investor considerations

Cincera Therapeutics
Drug discovery research at Monash resulted in a spin-out company to develop therapies for metabolic syndrome and type-2 diabetes-related diseases. https://cinceratx.com/

In the news https://www.monash.edu/news/articles/from-lab-to-industry,-monash-linked-start-up-attracts-$7m-investment